Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-19T23:29:21.220Z Has data issue: false hasContentIssue false
  • English
  • Français

Successful management of fetal hydrops due to congenitally complete atrioventricular block

Published online by Cambridge University Press:  24 May 2005

Jacintha Sivarajah ,
Ian C. Huggon  and
Eric Rosenthal
Jacintha Sivarajah
Affiliation:
Department of Paediatric Cardiology, Guy's Hospital, London, UK
Ian C. Huggon
Affiliation:
Fetal Cardiology Unit, Harris Birthright Research Centre for Fetal Medicine, Kings College Hospital, London, UK
Eric Rosenthal
Affiliation:
Department of Paediatric Cardiology, Guy's Hospital, London, UK
Get access Rights & Permissions [Opens in a new window]

Abstract

At 32 weeks, a fetus was found to be hydropic with congenitally complete heart block in an asymptomatic mother who was positive to anti-Ro antibodies. Maternal therapy with oral salbutamol was successful in prolonging gestation for a period of 3 weeks so that preterm delivery was delayed until the 35th week of gestation. Following treatment with inotropes and diuretics, a permanent transvenous pacemaker was implanted at 8 weeks of age. The child is now thriving at 20 months of age.

Keywords

Fetal hydropsheart blocksalbutamolpacemaker
Type
Brief Report
Information
Cardiology in the Young , Volume 13 , Issue 4 , August 2003 , pp. 380 - 383
Copyright
© 2003 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Groves A, Allan LD, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 1996; 75: 190–194.Google Scholar
Schmidt K, Ulmer H, Silverman N, Kleinman C, Copel J. Perinatal outcome of fetal complete atrioventricular block: a multicenter exeperience. J Am Coll Cardiol 1991; 17: 1360–1366.Google Scholar
Ho SY, Esscher E, Anderson RH, Michaëlsson M. Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol 1986; 58: 291–294.Google Scholar
Waltuck J, Buyon J. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120: 544–551.Google Scholar
Richards DS, Wagman AJ, Cabaniss ML. Ascites not due to congestive heart failure in a fetus with lupus-induced heart block. Obstet Gynecol 1990; 76: 957–959.Google Scholar
Groves A, Allan L, Rosenthal E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 1995; 92: 3394–3396.Google Scholar
Carpenter R, Strasburger J, Garson A, Smith R, Deter R, Engelhardt HT. Fetal ventricular pacing for hydrops secondary to complete atrioventricular block. J Am Coll Cardiol 1986; 8: 1434–1436.Google Scholar
Silverman MH, Kohl TE, Harrison MR, Hanley FL. Experimental surgery in the animal model and in the human fetus. In: Proceedings of the second world congress of paediatric cardiology and cardiac surgery, Honolulu, Hawaii, 1997; 106.
Robinson BV, Ettedgui JA, Sherman RS. Use of terbutaline in the treatment of complete heart block in the fetus. Cardiol Young 2001; 11: 683–686.Google Scholar
Weindling S, Saul JP, Triedman J, et al. Staged pacing therapy for congenital complete heart block in premature infants. Am J Cardiol 1994; 74: 412–413.Google Scholar